Cited by 453Inflammatory Bowel DiseasePsoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

Elson, Charles O., Cong, Yingzi, Weaver, Casey T., Schoeb, Trenton R., McClanahan, Terrill K., Fick, Robert B., Kastelein, Robert A.·2007·Gastroenterology

Abstract

Background & aims Interleukin (IL)-23 supports a distinct lineage of T cells producing IL-17 (Th17) that can mediate chronic inflammation. This study was performed to define the role of IL-23 and Th17 cells in chronic colitis in mice. Methods Colitis was induced by transfer of a cecal bacterial antigen-specific C3H/HeJBir (C3Bir) CD4(+) T-cell line to C3H/HeSnJ SCID mice. Cytokines were measured by flow cytometry, enzyme-linked immunosorbent assay, and real-time polymerase chain reaction. Monoclonal anti-IL-23p19 was administered at the same time as or 4 weeks after pathogenic CD4 T-cell transfer. A histopathology colitis score was assessed in a blinded fashion. Results The pathogenic C3Bir CD4(+) T-cell line contained more cells producing IL-17 than those producing interferon-gamma and these were distinct subsets; after adoptive transfer to SCID recipients, Th17 cells were predominant in the lamina propria of mice with colitis. Bacteria-reactive CD4(+) Th1 and Th17 lines were generated. The Th17 cells induced marked inflammation in a dose-dependent manner. Even at a dose as low as 10(4) cells/mouse, Th17 cells induced more severe disease than Th1 cells did at 10(6) cells/mouse. Monoclonal anti-IL-23p19 prevented and treated active colitis, with down-regulation of a broad array of inflammatory cytokines and chemokines in the colon. Anti-IL-23p19 induced apoptosis in colitogenic Th17 cells in vitro and in vivo. Conclusions Bacterial-reactive CD4(+) Th17 cells are potent effect…

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2007.03.104

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ongoing IL-6 signaling is indispensable and foundational, acting upstream of IL-23 via its unique function to sustain RORγt expression and thereby IL-23R expression.

    “Although it has been reported that IL-23 signaling is important for the maintenance of Th17 cells (18, 19, 21), we find that ongoing IL-6 signaling is indispensable and foundational, acting upstream of IL-23 via its unique function to sustain RORγt expression and thereby IL-23R expression.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B., & Kastelein, R. A.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
Elson, Charles O.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2007-06
Volume
132
Issue
7
Pages
2359-2370
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1964300433
Cited by
453
References
6
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 12 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 24 · 2015: 26 · 2014: 23 · 2013: 35 · 2012: 46
FWCI
27.60
Type
journal article
Language
en
Open access
closed
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R24DK064400, P01DK071176, DK064400, P01DK044240)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
IL-23, IL-23p19, Th17 cells, IL-17, chronic colitis, inflammatory bowel disease, anti-IL-23 monoclonal antibody, adoptive T cell therapy, CD4+ T cells, lamina propria inflammation, Th1 cells, apoptosis, chemokines, inflammatory cytokines
MeSH terms
Animals, Antibodies, Monoclonal, Antigens, Bacterial, Cecum, Cell Line, Colitis, Dendritic Cells, Disease Models, Animal, Interferon-gamma, Mice, Inbred C3H, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Mice, SCID, Interleukin-12, Adoptive Transfer, Interleukin-17, Mice, Interleukin-23, Interleukin-23 Subunit p19

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review